“…Elevated serum Cu/Zn ratio is indicative of nutritional deficiencies, oxidative stress, inflammation, and immune abnormalities [ 290 ], contributing to an increased risk of all-cause, cancer, and cardiovascular-related mortalities [ 291 ]. It also serves as a common biomarker of frailty linked with multiple-cause mortality in the elderly and of advancement of chronic disease [ 292 , 293 ] but also as a biomarker for children predisposed for numerous pediatric diseases, including vascular complications, cancers, and virus infections, and for neonates with early-onset congenital infections [ 294 , 295 , 296 , 297 , 298 ]. What leads to altered plasma Cu/Zn ratios is still, however, unknown [ 299 ].…”